Source link : https://www.newshealth.biz/health-news/can-dendritic-cells-improve-erbb2-breast-cancer-outcomes/
TOPLINE: For patients with early-stage ERBB2 (formerly HER2)–positive breast cancer, injections of increasing doses of autologous conventional type 1 dendritic cells (cDC1) combined with ERBB2-targeted antibodies demonstrate safety and effectiveness in enhancing immune response. The higher dose (100 million cells) shows enhanced immune effector recruitment and significant tumor regression before chemotherapy initiation. METHODOLOGY: ERBB2-positive breast […]
Author : News Health
Publish date : 2024-12-06 11:48:32
Copyright for syndicated content belongs to the linked Source.